Compare ASPN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPN | EVO |
|---|---|---|
| Founded | 2001 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 363.8M | 778.3M |
| IPO Year | 2011 | 2007 |
| Metric | ASPN | EVO |
|---|---|---|
| Price | $5.10 | $1.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.25 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 1.7M | 43.3K |
| Earning Date | 05-07-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $271,103,000.00 | N/A |
| Revenue This Year | N/A | $1.37 |
| Revenue Next Year | $50.03 | $10.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $1.89 |
| 52 Week High | $9.35 | $4.27 |
| Indicator | ASPN | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 40.65 |
| Support Level | $5.11 | $1.90 |
| Resistance Level | $5.77 | $2.20 |
| Average True Range (ATR) | 0.48 | 0.05 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 18.01 | 20.97 |
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.